ATE12102T1 - Salicylderivate von n-acetyl-cystein. - Google Patents

Salicylderivate von n-acetyl-cystein.

Info

Publication number
ATE12102T1
ATE12102T1 AT82201443T AT82201443T ATE12102T1 AT E12102 T1 ATE12102 T1 AT E12102T1 AT 82201443 T AT82201443 T AT 82201443T AT 82201443 T AT82201443 T AT 82201443T AT E12102 T1 ATE12102 T1 AT E12102T1
Authority
AT
Austria
Prior art keywords
acetylcysteine
acetyl cysteine
acid
reaction
acetylsalicylic acid
Prior art date
Application number
AT82201443T
Other languages
English (en)
Inventor
Osvaldo Ponchiroli
Original Assignee
Isnardi Pietro & C Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isnardi Pietro & C Spa filed Critical Isnardi Pietro & C Spa
Application granted granted Critical
Publication of ATE12102T1 publication Critical patent/ATE12102T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT82201443T 1981-11-20 1982-11-12 Salicylderivate von n-acetyl-cystein. ATE12102T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT25198/81A IT1194117B (it) 1981-11-20 1981-11-20 Derivati salicilici di n-acetilcisteina
EP82201443A EP0080229B1 (de) 1981-11-20 1982-11-12 Salicylderivate von N-Acetyl-Cystein

Publications (1)

Publication Number Publication Date
ATE12102T1 true ATE12102T1 (de) 1985-03-15

Family

ID=11215991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82201443T ATE12102T1 (de) 1981-11-20 1982-11-12 Salicylderivate von n-acetyl-cystein.

Country Status (9)

Country Link
US (1) US4567163A (de)
EP (1) EP0080229B1 (de)
JP (1) JPS58146560A (de)
KR (1) KR890000618B1 (de)
AT (1) ATE12102T1 (de)
CA (1) CA1202618A (de)
DE (1) DE3262569D1 (de)
ES (1) ES8402258A1 (de)
IT (1) IT1194117B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
IT1206515B (it) * 1983-08-09 1989-04-27 Guidotti & C Spa Labor N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
WO1995000136A1 (en) * 1993-06-18 1995-01-05 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
AU2825295A (en) * 1994-06-13 1996-01-05 Arcturus Pharmaceutical Corporation Method for the treatment, prevention or minimization of hair loss
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
JP5669729B2 (ja) * 2008-05-13 2015-02-12 ジェンメディカ・セラピューティックス・ソシエダッド・リミターダGenmedica Therapeutics Sl 代謝性障害を治療するのに有用なサリチレートコンジュゲート
JP2012520343A (ja) * 2009-03-16 2012-09-06 ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ 代謝障害治療のための併用療法
CA2755069A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
US20150025006A1 (en) 2011-09-16 2015-01-22 Genmedica Therapeutics Sl Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders
WO2013037984A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
WO2015070034A1 (en) 2013-11-08 2015-05-14 Promentis Pharmaceuticals, Inc. Substituted n-acetyl-l-cysteine derivatives and related compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4619M (de) * 1965-02-01 1966-11-28
US4268456A (en) * 1979-09-24 1981-05-19 Ppg Industries, Inc. Process for preparing chlorothiolformates

Also Published As

Publication number Publication date
DE3262569D1 (en) 1985-04-18
KR890000618B1 (ko) 1989-03-22
ES517540A0 (es) 1984-01-16
CA1202618A (en) 1986-04-01
IT1194117B (it) 1988-09-14
JPH059424B2 (de) 1993-02-04
JPS58146560A (ja) 1983-09-01
EP0080229A1 (de) 1983-06-01
EP0080229B1 (de) 1985-03-13
KR840002350A (ko) 1984-06-25
IT8125198A0 (it) 1981-11-20
US4567163A (en) 1986-01-28
ES8402258A1 (es) 1984-01-16

Similar Documents

Publication Publication Date Title
ATE12102T1 (de) Salicylderivate von n-acetyl-cystein.
NO924433D0 (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
SE8005890L (sv) Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter
FI822414L (fi) Syror av n-substituerade 2-pyrrolidon-4-karboxylsyror som befuktningsmedel
DE69811111D1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
ES390860A1 (es) Procedimiento para la produccion de un acido alfa - halofe-nilacetico sustituido.
DK164176A (da) Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler
FR2294742A1 (fr) Elimination de l'anhydride sulfureux d'un courant gazeux par absorption dans un milieu contenant des composes ammoniacaux
FI843264A (fi) Foerfarande foer framstaellning av antimikrobiella bensoesyraderivat.
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
ES534958A0 (es) Procedimiento de preparar derivados cisteinicos
ATE35811T1 (de) Derivat der acetylsalicylsaeure, seine herstellung und dieses enthaltende pharmazeutische kompositionen.
JPS5266885A (en) Gel composition containing water soluble organic medium
JPS52125194A (en) Stabilized s-adenosyl-l-methionine composition
IT1207985B (it) Derivati dell'acido 2-fenossipropionico e pentiti, procedimento per preparare questi composti e mezzi con effetto erbicida che li contengono.
ATE30024T1 (de) Carbamate und oxalylamide von amino-n-(1htetrazol-5-yl)benzamiden.
JPS5299994A (en) Stabilization of aqueous solution of basic aluminum salt
DK550177A (da) Basisk alkylerede dithiosalicylsyreamider fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
FR2044356A5 (en) 2-phenyl propionyl salicylic acid and salts - analgesics and antipyretics
SU565494A1 (ru) ω-орто-хлоранилид α-изобутил-β-метилглутаровой кислоты или его натриевая соль, проявляющие противовоспалительную и анальгезирующую активность
KR870003788A (ko) 모발자극 화합물
ES430197A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil) - delta7-desoxi-normorfinas y -norcodeina.
ES8800144A1 (es) Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico
MX3084E (es) Procedimiento para la obtencion de 2 - imino - 3 - ( 2 - cloro - 2 - fenil - etil ) tiazo lidina
Sampat et al. Sodium Diethyldithiocarbamate as an Inhibitor for the Corrosion of Aluminum in Trichloroacetic Acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee